C07D 233/54
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other
Official title: having two double bonds between ring members or between ring members and non-ring members
C07D233/54 (Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other) appears on 9,513 US grants and 6,014 published applications in this corpus.
Search patents in C07D- Granted patents
- 9,513
- Published applications
- 6,014
- Assignees
- 2,632
- Inventors
- 20,414
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 119 | 0 |
| 1977 | 114 | 0 |
| 1978 | 129 | 0 |
| 1979 | 112 | 0 |
| 1980 | 186 | 0 |
| 1981 | 148 | 0 |
| 1982 | 151 | 0 |
| 1983 | 130 | 0 |
| 1984 | 163 | 0 |
| 1985 | 186 | 0 |
| 1986 | 209 | 0 |
| 1987 | 185 | 0 |
| 1988 | 196 | 0 |
| 1989 | 261 | 0 |
| 1990 | 275 | 0 |
| 1991 | 247 | 0 |
| 1992 | 247 | 0 |
| 1993 | 240 | 0 |
| 1994 | 187 | 0 |
| 1995 | 189 | 0 |
| 1996 | 222 | 0 |
| 1997 | 244 | 0 |
| 1998 | 232 | 0 |
| 1999 | 237 | 0 |
| 2000 | 213 | 0 |
| 2001 | 222 | 44 |
| 2002 | 287 | 251 |
| 2003 | 264 | 382 |
| 2004 | 181 | 442 |
| 2005 | 211 | 303 |
| 2006 | 222 | 269 |
| 2007 | 195 | 278 |
| 2008 | 149 | 266 |
| 2009 | 159 | 271 |
| 2010 | 214 | 279 |
| 2011 | 185 | 247 |
| 2012 | 188 | 250 |
| 2013 | 199 | 197 |
| 2014 | 246 | 234 |
| 2015 | 201 | 229 |
| 2016 | 179 | 217 |
| 2017 | 198 | 237 |
| 2018 | 173 | 195 |
| 2019 | 168 | 185 |
| 2020 | 149 | 226 |
| 2021 | 156 | 185 |
| 2022 | 116 | 158 |
| 2023 | 107 | 194 |
| 2024 | 146 | 155 |
| 2025 | 104 | 155 |
| 2026 | 72 | 165 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Imidazole-based synthetic lipidoids for in vivo mRNA delivery into immune cells29 Sep 2026US 12,747,214 B2Trustees of Tufts College
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Amino acid compositions22 Sep 2026US 12,741,941 B2ThermoLife International, LLC
- Imidazole compounds as inhibitors of ENPP122 Sep 2026US 12,741,963 B2Stingray Therapeutics, Inc.
- Solid state forms of Nirogacestat salts15 Sep 2026US 12,734,152 B2Assia Chemical Industries Ltd.
- Compounds and compositions for treating glucose hypometabolic disorders8 Oct 2026US 2026/0306523 A1Senovia Biosciences LLC
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Amino acid backbone ionizable lipid, preparation method thereof and application method therefor1 Oct 2026US 2026/0294811 A1South China University of Technology
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications1 Oct 2026US 2026/0297012 A1NucMito Pharmaceuticals Co. Ltd.
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Alkynyl and azido-substituted 4-anilinoquinazolines379US 5,747,498 APfizer Inc. · 1998
- Method for deuteration of a heterocyclic ring304US 7,517,990 B2Wako Pure Chemical Industries, Ltd. · 2009
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997
- 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation222US 5,616,601 AG. D. Searle & Co. · 1997